This is the primary pathway for the metabolism of moderate to low amounts of ethanol, which takes place in the liver, primarily. Ethanol (alcohol) is converted to acetaldehyde by the enzyme alcohol dehydrogenase which catalyse this conversion. With this conversion, nicotinamide adenine dinucleotide also known as NAD+ (an co-enzyme), is also converted to NADH. This pathway is dependent on this co-enzyme and thus follows zero-order kinetics (Brand, 2021; Katzung, 2018).
Note: Small amounts of alcohol dehydrogenase is found in the stomach and brain (Katzung, 2018).
Ethanol is converted to acetaldehyde with MEOS. With this conversion, NADPH (co-factor) and oxygen is also converted to NADP+ and water (Katzung, 2018)
Both these pathways forms acetaldehyde which are then further converted to acetate with the enzyme aldehyde dehydrogenase and the co-enzyme NAD+, which is in turn converted to NADH (Katzung, 2018).
The effect of this inhibiting will cause the accumulation of ethanol in the body due to the fact that it cannot be converted acetaldehyde.
The effect of the inhibition of aldehyde dehydrogenase: Acetaldehyde cannot be converted to acetic acid and accumulates in the body (Brand, 2021). Acetaldehyde is toxic to the body’s cells and liver. The result of ethanol use together with these drugs, causes the patient to have symptoms of: nausea, hypotension, throbbing, confusion, flushing, headache, sweating and vomiting (Katzung, 2018).
Reference list
Katzung, B.G. 2018. Basic & Clinical Pharmacology. 14th ed. International: Mc Graw Hill Education.
Brand, L. 2021. Alcohols. SU 3 [pdf]. Unpublished lecture notes on eFundi, FKLG 312. Potchefstroom: NWU.